Similar Papers

Paper Title
Journal
Date
Author
Abstract 41: A novel high-throughput microfluidic drug screening platform using pancreatic ductal adenocarcinoma derived organoids
Bart Kramer ... Wijnand Van Paassen
Cancer Research | VOL. 79
Bart Kramer, et. al.Bart Kramer ... Wijnand Van Paassen
01 Jul 2019
Tissue-Engineered 3D In Vitro Disease Models for High-Throughput Drug Screening.
Gillian Huskin ... Trenton Davis
Tissue Engineering and Regenerative Medicine | VOL. 20
Gillian Huskin, et. al.Gillian Huskin ... Trenton Davis
09 Mar 2023
Abstract 4990: High-throughput drug combination screening in tumor spheroids identifies context-dependent synthetic lethalities
Wojciech Senkowski ... Kim Kultima
Cancer Research | VOL. 77
Wojciech Senkowski, et. al.Wojciech Senkowski ... Kim Kultima
01 Jul 2017
The 2020 SLAS Technology Ten: Translating Life Sciences Innovation.
Edward Kai-Hua Chow
SLAS technology | VOL. 25
Edward Kai-Hua ChowEdward Kai-Hua Chow
20 Jan 2020
View more papers

More From: Journal of Pharmaceutical Analysis

Paper Title
Journal
Date
Author
GPCRs identified on mitochondrial membranes: New therapeutic targets for diseases.
Yanxin Pan ... Qianming Chen
Journal of Pharmaceutical Analysis | VOL. -
Yanxin Pan, et. al.Yanxin Pan ... Qianming Chen
01 Jan 2025
Breaking Barriers: MS-BDF Tools in the Quality Control of Insect-derived Traditional Chinese Medicine
Caixia Yuan ... Caisheng Wu
Journal of Pharmaceutical Analysis | VOL. -
Caixia Yuan, et. al.Caixia Yuan ... Caisheng Wu
01 Jan 2025
Zebrafish as a Vertebrate Model for High-Throughput Drug Toxicity Screening: Mechanisms, Novel Techniques, and Future Perspectives
Wenhao Wang ... Ping Xiao
Journal of Pharmaceutical Analysis | VOL. -
Wenhao Wang, et. al.Wenhao Wang ... Ping Xiao
01 Jan 2025
Identify drug-drug interactions via deep learning:a real world study
Jingyang Li ... Jian Xiao
Journal of Pharmaceutical Analysis | VOL. -
Jingyang Li, et. al.Jingyang Li ... Jian Xiao
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.